RELATION OF AUTONOMOUS AND INTERLEUKIN-2-RESPONSIVE GROWTH OF LEUKEMIC-CELLS TO SURVIVAL IN ADULT T-CELL LEUKEMIA

Citation
N. Arima et al., RELATION OF AUTONOMOUS AND INTERLEUKIN-2-RESPONSIVE GROWTH OF LEUKEMIC-CELLS TO SURVIVAL IN ADULT T-CELL LEUKEMIA, Blood, 87(7), 1996, pp. 2900-2904
Citations number
23
Categorie Soggetti
Hematology
Journal title
BloodACNP
ISSN journal
00064971
Volume
87
Issue
7
Year of publication
1996
Pages
2900 - 2904
Database
ISI
SICI code
0006-4971(1996)87:7<2900:ROAAIG>2.0.ZU;2-Y
Abstract
We examined autonomous and interleukin-2 (IL-2)-responsive growth acti vities of leukemic cells derived from peripheral blood, as well as sev eral clinical manifestations, including serum lactate dehydrogenase (L DH) level, of 35 patients with adult T-cell leukemia (ATL) to determin e whether these properties were related to prognosis. Growth activitie s were measured by [H-3]-thymidine incorporation of the cells after 24 hours' culture with or without exogenous IL-2, Both autonomous and IL -2-responsive growth activities were higher in the patients than in he althy controls and were significantly correlated with each other (P < .0001, r = .956). Both higher growth activities were significantly ass ociated with shorter survival times (P = .0042, r = .472 and P = .0117 , r = .421, respectively). An increased serum LDH value was also signi ficantly associated with shorter survival times (P = .0011, r = .530), but corrected calcium level, sex, white blood cell count, or age were not. These results strongly suggest that both growth activities of pr imary tumor cells, in addition to the serum LDH value, are prognostic determinants in ATL. We propose a new prognostic classification combin ing LDH values and autonomous growth activity into three groups: (1) h igh growth activity and high LDH; (2) high growth activity and low LDH , or low growth activity and high LDH; and (3) low growth activity and low LDH, which showed a significant relationship to survival time (P = .0014; the median survival time for each group was 39, 94, and 340 d ays, respectively). (C) 1996 by The American Society of Hematology.